Cygnal Therapeutics

Cygnal Therapeutics, founded by Flagship Pioneering in 2017, is the first company to build a platform for drug development in the field of exoneural biology. Driven by their Exoneural Medicine Platform™, Cygnal Therapeutics is developing new drugs across multiple therapeutic areas including cancer and inflammatory diseases.